The analysis of the incidence of patients with salivary gland pathology in Altai region based on the data of oral maxillofacial surgery depatment at city hospital № 5 in Barnaul

Abstract


The purpose of the research was to study the prevalence of salivary gland pathology in Altai region depending on the patients’ age and sex. The study found that the patients aged 31-60 were more likely to have been admitted to the in-patient department. The patients were predominantly female and the cause of hospitalization was salivolithiasis. Pleomorphic adenomas were prevalent among salivary gland neoplasms. The results of the study allow to determine the true incidence rate and the needs to provide the appropriate medical care to this group of patients in Altai region.


Full Text

Restricted Access

About the authors

Aleksandr Vladimirovich Fefelov

Altai state medical University Ministry of health of Russia

Author for correspondence.
Email: fefelov.aleksander@yandex.ru
656038, Barnaul

cand. med. Sci., associate Professor

A. Yu Karasev

Altai state medical University Ministry of health of Russia

Email: info@eco-vector.com
656038, Barnaul

References

  1. Афанасьев В.В. Слюнные железы. Болезни и травмы: Руководство для врачей. М.: ГЭОТАР-Медиа; 2012.
  2. Афанасьев В.В., Абдусаламов М.Р. Атлас заболеваний и повреждений слюнных желез. М.: ВУНМЦ Росздрава; 2008.
  3. Ромачева И.Ф., Юдин Л.А., Афанасьев В.В. и др. Заболевания и повреждения слюнных желез. М.: Медицина; 1987.
  4. Шипский А.В., Афанасьев В.В. Диагностика хронических заболеваний слюнных желез с помощью дифференциально-диагностического алгоритма: Практическое руководство. М.: ГОУ ВУНМЦ МЗ РФ; 2001.
  5. Sialadenosis and Sialadenitis: Pathophysiological and Diagnostic Aspects / Eds C.R. Pfaltzh, R. Chilla. Basel: Karger; 1981.

Statistics

Views

Abstract - 22

PDF (Russian) - 0

Cited-By


Article Metrics

Metrics Loading ...

Refbacks

  • There are currently no refbacks.


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies